Pierce K L, Maudsley S, Daaka Y, Luttrell L M, Lefkowitz R J
Howard Hughes Medical Institute, Departments of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1489-94. doi: 10.1073/pnas.97.4.1489.
Acting through a number of distinct pathways, many G protein-coupled receptors (GPCRs) activate the extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) cascade. Recently, it has been shown that in some cases, clathrin-mediated endocytosis is required for GPCR activation of the ERK/MAPK cascade, whereas in others it is not. Accordingly, we compared ERK activation mediated by a GPCR that does not undergo agonist-stimulated endocytosis, the alpha(2A) adrenergic receptor (alpha(2A) AR), with ERK activation mediated by the beta(2) adrenergic receptor (beta(2) AR), which is endocytosed. Surprisingly, we found that in COS-7 cells, ERK activation by the alpha(2A) AR, like that mediated by both the beta(2) AR and the epidermal growth factor receptor (EGFR), is sensitive to mechanistically distinct inhibitors of clathrin-mediated endocytosis, including monodansylcadaverine, a mutant dynamin I, and a mutant beta-arrestin 1. Moreover, we determined that, as has been shown for many other GPCRs, both alpha(2A) and beta(2) AR-mediated ERK activation involves transactivation of the EGFR. Using confocal immunofluorescence microscopy, we found that stimulation of the beta(2) AR, the alpha(2A) AR, or the EGFR each results in internalization of a green fluorescent protein-tagged EGFR. Although beta(2) AR stimulation leads to redistribution of both the beta(2) AR and EGFR, activation of the alpha(2A) AR leads to redistribution of the EGFR but the alpha(2A) AR remains on the plasma membrane. These findings separate GPCR endocytosis from the requirement for clathrin-mediated endocytosis in EGFR transactivation-mediated ERK activation and suggest that it is the receptor tyrosine kinase or another downstream effector that must engage the endocytic machinery.
许多G蛋白偶联受体(GPCR)通过多种不同途径激活细胞外信号调节激酶(ERK)/丝裂原活化蛋白激酶(MAPK)级联反应。最近研究表明,在某些情况下,网格蛋白介导的内吞作用是GPCR激活ERK/MAPK级联反应所必需的,而在其他情况下则并非如此。因此,我们比较了由不发生激动剂刺激内吞作用的GPCR即α₂A肾上腺素能受体(α₂A AR)介导的ERK激活与由发生内吞作用的β₂肾上腺素能受体(β₂ AR)介导的ERK激活。令人惊讶的是,我们发现在COS-7细胞中,α₂A AR介导的ERK激活,与β₂ AR和表皮生长因子受体(EGFR)介导的激活一样,对网格蛋白介导的内吞作用的机制不同的抑制剂敏感,包括单丹磺酰尸胺、突变的发动蛋白I和突变的β-抑制蛋白1。此外,我们确定,正如许多其他GPCR所显示的那样,α₂A和β₂ AR介导的ERK激活都涉及EGFR的转活化。使用共聚焦免疫荧光显微镜,我们发现刺激β₂ AR、α₂A AR或EGFR均导致绿色荧光蛋白标记的EGFR内化。虽然β₂ AR刺激导致β₂ AR和EGFR都重新分布,但α₂A AR激活导致EGFR重新分布,而α₂A AR仍保留在质膜上。这些发现将GPCR内吞作用与EGFR转活化介导的ERK激活中网格蛋白介导的内吞作用需求区分开来,并表明必须是受体酪氨酸激酶或另一种下游效应器与内吞机制相互作用。